Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Teladoc Health Sees Q3 GAAP EPS $(0.35)-$(0.20) vs $(0.18) Est; Sees Sales $614.000M-$636.000M vs $628.009M Est

Author: Benzinga Newsdesk | July 29, 2025 03:13pm
Teladoc Health (NYSE:TDOC) is looking for Q3 GAAP EPS of $(0.35)-$(0.20) vs $(0.18) analyst estimate. sees sales of $614.000 million-$636.000 million vs $628.009 million analyst estimate.

Posted In: TDOC

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist